(Press-News.org) LOS ANGELES — Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, have collared a tricky culprit that helps cancer cells evade CAR T cell therapy.
CAR T cell therapy harnesses the immune system to seek out and kill tumor cells. This treatment is used in certain types of leukemia and lymphoma — blood cancers. Some wily cancer cells, however, have learned how to hide from the immune system to avoid destruction. The study published today in the journal Cell could lead to more personalized therapies that improve cancer patients’ survival.
The researchers identified a protein called YTHDF2 that plays a starring role in advancing the development of blood cancers. City of Hope then created a new medicinal compound called CCI-38, which targets and suppresses YTHDF2, reducing the growth of aggressive blood cancers. The approach improves the likelihood of successful cancer treatment.
“We believe that using CCI-38 to target YTHDF2 will significantly enhance the effectiveness of CAR T cell therapy on blood cancer cells,” said Jianjun Chen, Ph.D., Simms/Mann Family Foundation Chair in Systems Biology and the director of the Center for RNA Biology and Therapeutics at Beckman Research Institute of City of Hope.
“One of the challenges in treating blood cancers is a phenomenon called ‘antigen escape.’ A key target for these therapies is a protein called CD19 found on the cancer cells,” added Dr. Chen, corresponding author of the new study.
However, in 28-68% of cases, the cancer cells lower or lose this CD19 marker, making treatments less effective. Although researchers are working on strategies to target multiple components, nearly half of patients are still affected by this issue.
YTHDF2 switches on genes that help cancer cells produce a stable energy source to fuel the cells’ ability to grow and spread. Moreover, this protein helps cancer cells conceal themselves by reducing the presence of antigen biomarkers that normally trigger the immune system to detect and attack cancer. Lastly, excess YTHDF2 works like a werewolf’s bite to transform blood cells from healthy to cancerous in mouse studies.
“Reducing the need for follow-up treatments could lead to better long-term survival and less relapse for our patients while lowering side effects and medical costs,” said Xiaolan Deng, Ph.D., an associate research professor in systems biology at Beckman Research Institute of City of Hope and a co-corresponding author of the study.
City of Hope, a recognized leader in CAR T cell therapies for glioblastoma and other cancers, has treated more than 1,600 patients since its CAR T program started in the late 1990s. The institution continues to have one of the most comprehensive CAR T cell clinical research programs in the world.
“Unraveling the biology underlying YTHDF2’s function will help us develop new strategies to prevent tumor cells from escaping immune surveillance,” said Zhen-Hua Chen, Ph.D., a staff scientist in systems biology at Beckman Research Institute of City of Hope and first author of the study. “This could lead to personalized approaches for patients whose blood cancers don’t respond to initial treatment or who relapse after initial response to T cell-based immunotherapy.”
The City of Hope team has filed a patent application covering critical aspects of this work, which holds implications for improving care for patients with other cancers and severe autoimmune diseases. The next phase of research will focus on improving CCI-38’s safety and effectiveness, exploring new methods to drive YTHDF2 out of cancer cells, and developing clinical trials.
# # #
The Cell study “YTHDF2 promotes ATP synthesis and immune-evasion in B-cell malignancies,” was supported by a National Institutes of Health grant (P30CA33572), multiple NIH R01 grants to Dr. Jianjun Chen (CA280389, CA271497, CA243386, CA214965, CA236399 and CA211614), and funding from the Simms/Mann Family Foundation.
About City of Hope
City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.
END
The decades-old anesthetic ketamine could be a game changer for treating severe depression, but there are still many questions about how the drug works, including exactly how it affects the brain’s cells and circuits.
To help answer these questions, researchers are turning to an unlikely animal: tiny, days-old zebrafish.
The millimeters-long, translucent zebrafish may not get depressed exactly like humans do, but the fish do exhibit a “giving up” behavior: they stop swimming after they realize they aren’t getting anywhere – a passive behavior that scientists use to study ...
About The Study: In this cohort study of Dutch children, early-life moderate to vigorous physical activity was not associated with executive function in middle childhood. Children participating in team sports at ages 10 to 11 consistently exhibited superior executive function compared with participants in individual sports.
Corresponding Author: To contact the corresponding author, Lu Yang, MSc, email l.yang@umcg.nl.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.49879)
Editor’s Note: Please see ...
When doctors and nurses pass patient information from one shift to another — an exchange known as a “handoff” — the specific words they use behind closed doors matter more than they might realize. A new study published in JAMA Network Open shows that when clinicians hear a patient described with negatively biased language, they develop less empathy towards the patient and, in some cases, become less accurate in recalling the patient’s critical health details. Such shifts in perception may be subtle and unintentional in many cases, but as these hidden biases stack up, they can influence the care patients ultimately receive.
“A lot is going on here ...
Study shows how language, education and age affect someone’s ability to engage with digital health tools.
Digital health tools, such as patient portals, treatment apps and online appointment schedulers, are increasingly common. But not everyone is equally at home using them.
To find out how language, education and age may affect a person’s comfort in using digital tools, UC San Francisco researchers surveyed caregivers of hospitalized children at UCSF Benioff Children’s Hospitals.
The researchers found that being a Spanish speaker, having less education, and being older all made people feel less comfortable with digital health ...
Scientists mapped near-gap-free and near-error-free genomes of a susceptible bed bug strain and a superstrain around 20,000 times more insecticide-resistant, offering the broadest look yet at the full scope of their resistance mutations.
Their findings were published in the journal Insects.
Although there is no evidence that bed bugs transmit diseases to humans, their bites can cause itchy rashes and secondary skin infections. Widespread use of insecticides, including the now-banned DDT, nearly wiped out populations of these blood-sucking insects by the 1960s, making infestations ...
SAN ANTONIO — December 17, 2024 —NASA and the National Oceanic and Atmospheric Administration (NOAA) recently awarded Southwest Research Institute a $26 million contract to develop magnetometers for NOAA’s Space Weather Next (SW Next) program for two missions to be launched in 2029 and 2032. The magnetometers will measure the interplanetary magnetic field carried by the solar wind.
“The instruments provide critical data to NOAA’s Space Weather Prediction Center which issues forecasts, warnings and alerts that help mitigate space weather impacts,” said Dr. Roy Torbert, a program director in SwRI’s Earth, Oceans, and Space office ...
A new study has shown that employees are experiencing mental and physical techno-strain due to being ‘hyperconnected’ to digital technology making it difficult for people to switch off from work.
Researchers from the University of Nottingham’s Schools of Psychology and Medicine conducted detailed interviews with employees from a range of professions and found that the cognitive and affective effort associated with constant connectivity and high work pace driven by the digital workplace is detrimental to employee wellbeing. The results have been published today in Frontiers in Organizational Psychology.
This new paper is the final part of a research ...
Image
Adolescent drug use continued to drop in 2024, building on and extending the historically large decreases that occurred during the pandemic onset in 2020.
"I expected adolescent drug use would rebound at least partially after the large declines that took place during the pandemic onset in 2020, which were among the largest ever recorded," said Richard Miech, team lead of the Monitoring the Future study at U-M's Institute for Social Research.
"Many experts in the field had anticipated that drug use would resurge ...
NEW YORK CITY and ORLANDO— The American Federation for Aging Research (AFAR) and the McKnight Brain Research Foundation (MBRF) are pleased to announce the 2024 recipients of The McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss: Janine Kwapis, PhD, of Pennsylvania State University, and Sanaz Sedaghat, PhD, of the University of Minnesota.
Now in its fourth year, the Innovator Awards provide funding to research scientists pursuing groundbreaking studies in the field of cognitive aging.
Janine Kwapis, PhD, is an Assistant Professor and Paul Berg Early Career Professor ...
Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a recent study reports an underuse of the treatment.
“Antiviral Use Among Children Hospitalized with Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study” was published in Clinical Infectious Diseases, the flagship journal of the Infectious Diseases Society of America.
Flu illness accounts for up to 10% of all pediatric hospitalizations during ...
